Skip to Content

ImmunoPrecise Antibodies Ltd IPA

Morningstar Rating
$1.05 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IPA is trading at a 267% premium.
Price
$1.04
Fair Value
$8.86
Uncertainty
Extreme
1-Star Price
$2.67
5-Star Price
$2.63
Economic Moat
Qdh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IPA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.05
Day Range
$1.021.07
52-Week Range
$0.943.21
Bid/Ask
$1.02 / $1.06
Market Cap
$27.63 Mil
Volume/Avg
75,498 / 118,876

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.51
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
102

Comparables

Valuation

Metric
IPA
IBRX
NYKD
Price/Earnings (Normalized)
Price/Book Value
0.742.88
Price/Sales
1.5141.59
Price/Cash Flow
Price/Earnings
IPA
IBRX
NYKD

Financial Strength

Metric
IPA
IBRX
NYKD
Quick Ratio
1.183.218.43
Current Ratio
1.663.648.43
Interest Coverage
−387.88−3.40
Quick Ratio
IPA
IBRX
NYKD

Profitability

Metric
IPA
IBRX
NYKD
Return on Assets (Normalized)
−15.85%−119.98%−18.26%
Return on Equity (Normalized)
−22.58%−23.64%
Return on Invested Capital (Normalized)
−19.91%−188.07%−26.98%
Return on Assets
IPA
IBRX
NYKD
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
WljwvnyscJxwfkb$124.1 Bil
Regeneron Pharmaceuticals Inc
REGN
YmddwvntCxbzrf$114.2 Bil
Moderna Inc
MRNA
JmtlzwkwhBgjh$53.7 Bil
argenx SE ADR
ARGX
FjfksjpzGkt$23.0 Bil
BioNTech SE ADR
BNTX
FzrmpjgpzXylm$22.2 Bil
Alnylam Pharmaceuticals Inc
ALNY
HrplvrpgWrrdbm$20.3 Bil
Biomarin Pharmaceutical Inc
BMRN
LhwthvjqGmmfb$15.9 Bil
United Therapeutics Corp
UTHR
GhsjmjmZdym$12.8 Bil
Incyte Corp
INCY
MvbnwfgpsJstmfd$12.2 Bil
Royalty Pharma PLC Class A
RPRX
PgmlthydnTgwvbn$12.2 Bil

Sponsor Center